Syndrome News and Research

RSS

Elevated and sustained autoantibodies following COVID-19

A new study demonstrated that autoantibody levels rise following acute SARS-CoV-2 infection and remain to be elevated for about six months.

10 May 2022

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

In this study, the authors have specifically studied the interactions of epithelial cells, a subset of cytokines and macrophages.

10 May 2022

Researchers report widespread prevalence of reactive and acute inflammatory CNS microvasculopathy in 36 COVID-19 brain autopsies

A new study has focused on the microcirculatory factors associated with neurological complications of COVID-19.

10 May 2022

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

A new paper published in Signal Transduction and Targeted Therapy reports the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2.

10 May 2022

Systematic review with meta-analysis of the current evidence regarding the incidence of long COVID symptomatology

The researchers searched several databases looking for observational studies on the incidence of long COVID symptoms and signs by organ system, based on the World Health Organization (WHO) criteria.

10 May 2022

The potential for SARS-CoV-2 to be transmitted biologically or mechanically by arthropods

Researchers examined results from field studies, laboratory-based research, and environmental studies to analyze the potential of SARS-CoV-2 transmission either biologically or mechanically among arthropods.

10 May 2022

SARS-CoV-2 Omicron infection boosts Delta immunity in those who have been vaccinated

A new study published in the journal Nature aimed to determine the extent to which Omicron infection elicits protection against other SARS-CoV-2 variants in both vaccinated and unvaccinated individuals.

10 May 2022

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

A study recently published in the journal Cell Host & Microbe has described that all three sublineages of the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit similar host cell entry efficiency and are neutralized equally by antibodies generated in response to coronavirus disease 2019 (COVID-19) booster vaccination

10 May 2022

About 15 million additional deaths attributed to COVID-19 between January 2020 and December 2021

The World Health Organization (WHO) has released new figures showing that the coronavirus disease 2019 (COVID-19) pandemic caused almost 15 million deaths directly or indirectly. These deaths comprise the excess mortality over the two years 2020 and 2021, attributable to infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

9 May 2022

More evidence that pediatric COVID vaccination prevents MIS-C

Researchers designed a nationwide pediatric COVID-19 research project based on real-time data since the early phase of the pandemic.

9 May 2022

Severe symptoms result in high titers of SARS-CoV-2 antibodies

Scientists have focused on determining the cause-effect relationship between SARS-CoV-2 antibody titers and COVID-19 disease severity.

9 May 2022

Complimentary tests to quantify cognitive changes in dogs could aid humans with Alzheimer's disease

Researchers have found that a suite of complimentary tests can quantify changes in dogs suspected of suffering from cognitive decline.

9 May 2022

Urgent action needed to address disparities in women’s heart health

Investing in and improving research, awareness and equity in women's heart health are critical for the health and well-being of women, according to a new Presidential Advisory from the American Heart Association, published today in the Association's flagship journal Circulation.

9 May 2022

Personalized text messaging program improves healthy lifestyle measures in heart attack survivors

A text messaging program successfully supported, informed and motivated people after a heart attack on how to prevent a second heart attack, according to new research published today in the American Heart Association's flagship, peer-reviewed journal Circulation.

9 May 2022

Syndrome News and Research

Elevated and sustained autoantibodies following COVID-19

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

Researchers report widespread prevalence of reactive and acute inflammatory CNS microvasculopathy in 36 COVID-19 brain autopsies

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

Systematic review with meta-analysis of the current evidence regarding the incidence of long COVID symptomatology

The potential for SARS-CoV-2 to be transmitted biologically or mechanically by arthropods

SARS-CoV-2 Omicron infection boosts Delta immunity in those who have been vaccinated

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

About 15 million additional deaths attributed to COVID-19 between January 2020 and December 2021

More evidence that pediatric COVID vaccination prevents MIS-C

Severe symptoms result in high titers of SARS-CoV-2 antibodies

Complimentary tests to quantify cognitive changes in dogs could aid humans with Alzheimer's disease

Urgent action needed to address disparities in women’s heart health

Personalized text messaging program improves healthy lifestyle measures in heart attack survivors

Exploring low serum volume assays for SARS-CoV-2 antibodies

Third BNT162b2 dose elicits more durable immune response than second dose

Deoxyribonucleic acid nanostructure sensor found to rapidly detect and inhibit SARS-CoV-2

Comparison of COVID-19 vaccination schemes

Correlating symptoms with COVID-19 test positivity in children

Differences in COVID-19 outcomes related to sex

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News